Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.3K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

599
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
599
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

595
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
595
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

469
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
469

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cell-free tumour DNA in bronchoalveolar lavage: a proof of concept study.

ERJ open research·2026
Same author

Early Intervention With Biologics for Asthma Remission: Promising or Premature?

Respirology (Carlton, Vic.)·2026
Same author

Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.

Lancet (London, England)·2026
Same author

Unrecognized ciliary motility disorders in neutrophilic severe asthma exacerbations.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same author

Clinical remission in allergy and clinical immunology practice: State of the art and World Allergy Organization (WAO) call to action.

The World Allergy Organization journal·2026
Same author

Dupilumab Reduces Mucus Radiodensity and New Plug Formation in Asthma.

Chest·2026

相关实验视频

Updated: Sep 15, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K

在严重喘中实现缓解.

Sarita Thawanaphong1,2,3, Santi Nolasco1,2, Parameswaran Nair1,2

  • 1Department of Medicine, McMaster University, Hamilton, ON L8N 3Z5, Canada.

Chinese medical journal pulmonary and critical care medicine
|July 18, 2025
PubMed
概括

生物疗法为严重喘提供了新的希望,改善肺功能并减少恶化. 实现喘缓解需要个性化治疗选择和先进的生物标志物,以获得更好的患者结果.

关键词:
生物制剂 生物制剂 生物制剂减免 减免 减免严重的喘 严重的喘

更多相关视频

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.6K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

3.9K

相关实验视频

Last Updated: Sep 15, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.6K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

3.9K

科学领域:

  • 肺病学和免疫学 肺病学和免疫学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 严重的喘影响全球5-10%的患者,导致显著的发病率和死亡率.
  • 2型炎症是严重喘的关键途径,是新兴生物疗法的目标.

研究的目的:

  • 审查严重喘生物疗法的疗效和机制.
  • 探索实现喘缓解的策略,包括生物药物和补充治疗.
  • 讨论优化治疗选择和严重喘管理的未来方向.

主要方法:

  • 关于严重喘的生物治疗现有文献的综述.
  • 对可用的生物制剂的作用机制,临床疗效和局限性的分析.
  • 探索用于个性化治疗的互补策略和新兴诊断工具.

主要成果:

  • 生物药物如奥马利祖马布,梅波利祖马布,雷斯利祖马布,本拉利祖马布和杜皮卢马布有效地减少恶化并改善特定患者的肺功能.
  • 目前使用生物药物的临床缓解率仍然很低,这凸显了改善患者选择的必要性.
  • 补充策略和先进的生物标志物显示出增强治疗精度和实现持续控制喘的前景.

结论:

  • 生物疗法在治疗严重喘方面取得了重大进展.
  • 以生物标志物和多组学为指导的个性化治疗方法对于改善结果和实现缓解至关重要.
  • 对可访问的照顾点生物标志物的进一步研究对于在严重喘中推进精准医学至关重要.